serena williams glp-1 and the coming reckoning with GLP-1s and performance enhancement Serena Williams Opens Up About
Description
Therapies that offer better efficacy could be saved for sicker diabetic patients
PMID 31750601
In just a single year, the number nearly doubled to 192
The next generation of treatments GLP-1 receptor agonists have transformed the management of type 2 diabetes and obesity, but their therapeutic potential extends far beyond glucose regulation
Adipose tissue reduction: Loss of intrahepatic and visceral fat with GLP-1RAs therapy is associated with decreased release of proinflammatory cytokines such as TNF-, IL-1, and IL-6 (Mehdi et al
Macrophages: versatile players in renal inflammation and fibrosis
